Metaplastic breast carcinoma most commonly exhibits triple-negative receptors via the absence of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2). Here, ERBB2 is linked to metaplastic breast carcinoma.